Hormonal Health Guides
Plain-language, editorially reviewed articles organized by topic. Every guide is checked against peer-reviewed medical literature and carries a last-reviewed date. Use the topic clusters below to dig into a specific area, or browse the chronological feed at /learn.
In-depth guides(55)
Hormone Therapy Options: Visual Guide
Estrogen, progesterone, and delivery routes compared at a glance.
Menopause Hair Loss: Treatment Options
Topical and oral minoxidil, spironolactone, HRT, and deficiencies to rule out.
Best Vaginal Moisturizers for Menopause
How moisturizers differ from lubricants and vaginal estrogen for GSM.
Vaginal pH Balance in Menopause
Why menopausal pH rises and what actually restores the acidic range.
Perimenopause Periods: What Changes
Cycle-length shifts, heavy bleeding, and when to see a clinician.
Hormone Harmony Review: Does It Work?
An evidence-based look at the ingredients, claims, and regulatory reality.
What Does Progesterone Do for Women?
Its role in the cycle, pregnancy, sleep and mood, and use in HRT.
Peptides for Weight Loss: What the Evidence Shows
FDA-approved GLP-1 peptides vs unapproved research peptides, honestly compared.
Weight-Loss Supplements for Women
What the evidence says about OTC options versus prescription GLP-1s.
Estrogen & Estriol Face Cream for Menopause
What the skin studies show, plus the US regulatory reality.
Heavy Periods with Clots After 40
Normal versus red-flag bleeding in perimenopause, and when to seek care.
Endometriosis and Menopause
Does endo end at menopause, and how HRT decisions change after it.
Progestin-Only Mini Pill
Who POPs suit, effectiveness, bleeding patterns, and the perimenopause angle.
Testosterone for Women
What the evidence supports (HSDD), what it does not, and how it is prescribed.
Bioidentical Hormones: Myth vs Fact
FDA-approved body-identical products versus compounded cBHT, honestly compared.
What Is a Hormone Therapist?
Who actually prescribes hormone therapy, which credentials matter, and how to find one.
Normal Estradiol Levels by Age
Reference ranges by cycle phase and life stage, the assay caveat, and when a test actually helps.
Do GLP-1 Patches Work?
Why there is no FDA-approved GLP-1 patch and the pharmacology that explains it.
Collagen for Menopause Skin
What the RCT evidence actually shows for skin elasticity — modest but real, vs the hype.
Low Libido in Menopause
Why desire changes and what has real evidence — from vaginal estrogen to testosterone for HSDD.
Menopause Fatigue: Causes & Fixes
A proper differential — not "just menopause": thyroid, iron, sleep apnea, and what helps.
What Is Retatrutide — Can You Get It?
The investigational triple-agonist: trial evidence, why it is not for sale, and the scam warning.
Does Berberine Work? ('Nature's Ozempic')
The viral claim, checked: modest metabolic effects — nowhere near a GLP-1 drug.
Is There a Best Estrogen Supplement?
There is no OTC estrogen — what phytoestrogens do and do not do, per NAMS.
Vitamin D3 + K2 in Menopause
What is proven for bone (D + calcium + exercise) and where K2 actually fits.
How Long Until Wegovy Works?
A realistic semaglutide 2.4 mg timeline — appetite first, full effect over months.
How Long Until Zepbound Works?
Tirzepatide-for-weight timeline: gradual titration, SURMOUNT-1 arc, what to expect.
How Long Until Mounjaro Works?
Diabetes-approved tirzepatide — glycemic timeline plus the honest off-label-weight caveat.
How Long Until Ozempic Works?
Diabetes-approved semaglutide — timeline and why weight use is off-label vs Wegovy.
How Long Until Tirzepatide Works?
The molecule behind Zepbound and Mounjaro: what to expect and which brand fits which goal.
Compounded Tirzepatide for Women
What it is, the FDA compounding wind-down, the tirzepatide birth-control interaction, and how to vet a program.
Semaglutide for Women (Wegovy & Ozempic)
Efficacy context, pregnancy caution, and why it does NOT carry the tirzepatide contraceptive warning.
Tirzepatide for Women (Zepbound & Mounjaro)
The oral-contraceptive interaction women need to know, pregnancy caution, and brand indications.
GLP-1 Drugs and Birth Control
Tirzepatide can reduce oral contraceptive effectiveness; plus restored ovulation and pregnancy cautions.
GLP-1 Medications for PCOS
Off-label for PCOS: the metabolic rationale, guideline context, and the contraception caveat.
Tirzepatide vs Retatrutide
FDA-approved dual agonist vs investigational triple agonist — and why no head-to-head trial exists.
Retatrutide vs Semaglutide
Investigational triple agonist vs approved GLP-1 — honest indirect comparison, no fabricated numbers.
Compounded vs Brand-Name Tirzepatide
A regulatory/safety comparison: FDA-approved potency vs unverified compounded, and the closing window.
Oral vs Injectable Semaglutide
Rybelsus vs Ozempic/Wegovy: route, approved use, and which form is the weight indication.
GLP-1 vs HRT for Menopause Weight
Different problems, not either/or — HRT is not a weight drug; where each actually fits.
Why Is My Period Early? Causes & When to Worry
Cycle-shortening in perimenopause vs the causes that warrant a check.
Vitamins for Energy for Women
What the evidence supports for fatigue — and what to rule out first.
How to Lower High Testosterone (PCOS)
Evidence-based options for androgen excess, from lifestyle to medication.
Tretinoin for Menopause Skin
Rx retinoid with RCT evidence for photoaging — honestly, not a hormone or menopause fix.
Estradiol Vaginal Cream
Local low-dose estrogen for GSM: what it does, safety, and how it differs from a moisturizer.
Bleeding After Menopause: When to Worry
Any bleeding after menopause needs evaluation — benign causes, and how ultrasound and biopsy rule out cancer.
How Long Can You Take HRT?
NAMS 2022 does not support stopping at a set age or duration — how the decision is actually individualized.
Starting HRT: What to Expect
Which symptoms respond first, what the settling-in period looks like, and when to go back to the prescriber.
Slynd (Drospirenone) in Perimenopause
An estrogen-free progestin-only pill — what the FDA label covers, and why it is not menopausal hormone therapy.
Menopause Acne: Why It Starts After 40
The androgen-to-estrogen shift behind adult acne, and what dermatology guidelines actually support.
Perimenopause Cramps and Pelvic Pain
Cramps without a period, the structural causes that rise in your 40s, and which patterns need evaluation.
Thyroid or Menopause? Telling Them Apart
The symptom overlap is real — which features point where, and what testing actually settles it.
Oral Minoxidil for Women's Hair Loss
Low-dose oral minoxidil for female-pattern hair loss — emerging and off-label.
Spironolactone for Women's Hair Loss
Off-label anti-androgen for FPHL/hirsutism; teratogenic, so contraception matters.
Is Vaginal Estrogen Safe?
Local low-dose estrogen has minimal systemic absorption — plus the breast-cancer nuance.
Other(40)
Perimenopause Symptoms: A Complete Guide for Women 40+
Perimenopause begins on average at age 45 and can last 4-10 years. Here's what symptoms to expect, when to consider HRT, and which providers can help.
Reviewed 5/14/2026
STRAW+10 reproductive staging explained
STRAW+10 is the global clinical standard for staging reproductive aging — from late reproductive years through postmenopause. Knowing your stage shapes which treatments make sense.
Reviewed 5/10/2026
Bioidentical vs synthetic hormones: what the labels actually mean
"Bioidentical" describes molecular structure, not source or quality. Both FDA-approved and compounded products can be bioidentical. The label by itself tells you almost nothing about safety.
Reviewed 5/10/2026
Estradiol vs estrone vs estriol: the three estrogens explained
Estradiol, estrone, and estriol are the three main human estrogens. Each dominates at a different life stage. Knowing which matters when changes how you read your labs.
Reviewed 5/10/2026
FSH testing in perimenopause: when it helps and when it misleads
FSH testing is widely ordered for perimenopause but the single value fluctuates so much it usually misleads. Knowing the test's limits prevents wasted appointments.
Reviewed 5/10/2026
Perimenopause stages: what to expect across the transition
Perimenopause is a 5–10 year transition with predictable phases. Knowing which symptoms typically appear when reduces the "is this normal?" anxiety.
Reviewed 5/10/2026
HRT eligibility: who qualifies and who doesn't
HRT eligibility is broader than most women assume. The actual absolute contraindications are few; most "I was told I can't take it" is outdated guidance.
Reviewed 5/10/2026
Compounded vs FDA-approved HRT: what the difference actually means
Compounded hormone therapy is widely marketed but not FDA-approved. The active molecules can be identical to FDA versions — but regulation, dose accuracy, and safety oversight differ.
Reviewed 5/10/2026
The WHI study, properly contextualized: what 2002 said, what we know now
The 2002 WHI results triggered a 70% drop in HRT prescriptions. The re-analyses since then tell a different story than the headlines did — especially about timing.
Reviewed 5/10/2026
How to start HRT: the practical first 90 days
The first 90 days on HRT settle the question of whether it's working and tolerable. Knowing what to expect prevents premature discontinuation.
Reviewed 5/10/2026
Compounded vs branded GLP-1: semaglutide, Wegovy, tirzepatide, Zepbound
Compounded semaglutide and tirzepatide cost a fraction of branded Wegovy or Zepbound. The trade-offs in oversight, dose accuracy, and supply uncertainty matter.
Reviewed 5/10/2026
GLP-1 side effects in women: what to expect and what to call about
GLP-1 side effects are common but mostly mild and time-limited. Knowing the typical 8-week trajectory prevents premature discontinuation — and helps distinguish normal from warning.
Reviewed 5/10/2026
GLP-1 insurance coverage: navigating the reality in 2026
GLP-1 insurance coverage in 2026 varies wildly by plan, indication, and state. Knowing the landscape before you start saves months of denied claims.
Reviewed 5/10/2026
PCOS is four conditions, not one: the phenotype framework
PCOS is not one disease. Four phenotypes — insulin-resistant, inflammatory, adrenal, post-pill — explain why one woman's PCOS responds to metformin while another's doesn't.
Reviewed 5/10/2026
Rotterdam criteria: how PCOS is actually diagnosed
PCOS diagnosis uses the Rotterdam criteria — two of three features required. The criteria are widely misapplied; clarifying them reduces false labels.
Reviewed 5/10/2026
PCOS medications compared: metformin vs spironolactone vs GLP-1 vs OCP
Four primary PCOS medication classes — metformin, spironolactone, GLP-1, hormonal contraception — each target different aspects. The right choice depends on phenotype and priorities.
Reviewed 5/10/2026
How we score brands: the full methodology behind the composite
The composite 0–10 score has five weighted sub-axes. Each axis has explicit measurement rules — no editorial vibes-based scoring, no commercial influence.
Reviewed 5/10/2026
Telehealth vs in-person HRT: when each works best
Telehealth HRT has become clinically robust. In-person care still has specific advantages — knowing when each fits prevents both unnecessary clinic visits and inappropriate telehealth dependence.
Reviewed 5/10/2026
Red flags when choosing a telehealth HRT or GLP-1 provider
Most telehealth brands deliver real care. A small minority cut clinical corners or hide important information. Here are the red flags worth walking away over.
Reviewed 5/10/2026
Preparing for your first telehealth menopause visit
Thirty minutes of prep before your first telehealth menopause visit saves weeks of back-and-forth dose tuning. Here's the checklist that gets you to a working regimen faster.
Reviewed 5/10/2026
Estradiol Side Effects in Women: Complete Guide to Risks and Symptoms
Estradiol side effects range from mild breast tenderness and bloating in 10-30% of users to rare but serious risks like venous thromboembolism. Here's what the evidence says and what to discuss with your clinician.
Reviewed 5/29/2026
Hormone Testing Accuracy: Blood vs Saliva vs Urine Compared
Blood, saliva, and dried-urine hormone tests measure different fractions of the same hormones. Here's what current evidence says about accuracy, clinical use, and how telehealth providers order them.
Reviewed 5/29/2026
Hot Flashes Treatment: Evidence-Based Options for Menopausal Women
Hot flashes treatment ranges from hormone therapy (the gold standard, reducing frequency by 75%) to the newly FDA-approved non-hormonal fezolinetant, SSRIs, gabapentin, CBT, and lifestyle interventions. Here's what the evidence shows.
Reviewed 5/29/2026
How Much Does HRT Cost Without Insurance? 2026 Price Guide
A 2026 breakdown of cash-pay HRT pricing: estradiol patches, oral progesterone, telehealth visits, and compounded options. Typical out-of-pocket runs $15-$200/month before discount cards.
Reviewed 5/29/2026
HRT vs Non-Hormonal Menopause Treatment: Evidence-Based Comparison
A side-by-side look at HRT vs non-hormonal menopause options — covering hot-flash relief rates, contraindications, cost ranges, and telehealth provider differentiators for cash-pay vs insurance-covered care.
Reviewed 5/29/2026
Perimenopause Symptoms Checklist: 34 Signs Women Should Track
A complete, evidence-based perimenopause symptoms checklist covering 34 hormonal, physical, vasomotor, and cognitive signs — with prevalence data, tracking tips, and when to see a clinician.
Reviewed 5/29/2026
PMDD vs PMS: Key Differences, Symptoms & Diagnosis Explained
PMDD vs PMS: a NAMS-reviewed comparison covering severity thresholds, DSM-5 diagnostic criteria, prevalence data, and treatment options ranging from SSRIs to hormonal therapy.
Reviewed 5/29/2026
Progesterone Side Effects in Women: Complete Evidence-Based Guide
An evidence-based breakdown of progesterone side effects women report most often during HRT and luteal-phase use, including timeline, dose dependency, and what warrants a clinical conversation.
Reviewed 5/29/2026
Vaginal Estrogen Safety and Use: Evidence Guide for Menopause
A clinician-reviewed guide to vaginal estrogen safety: how low-dose formulations work, what the evidence says about cancer and cardiovascular risk, and what to discuss with a provider.
Reviewed 5/29/2026
Bioidentical Hormones Explained: Evidence, Risks, and Modern HRT Options
Bioidentical hormones are chemically identical to those the body produces. Here's what current evidence says about FDA-approved versus compounded options, safety, costs, and how telehealth providers prescribe them.
Reviewed 5/29/2026
How to Choose a Menopause Telehealth Provider: An Editorial Buyer's Guide
How to choose menopause telehealth comes down to seven factors: clinician credentials, state coverage, prescribing scope, lab handling, insurance model, communication cadence, and price transparency. This editorial guide walks through each.
Reviewed 5/30/2026
Compounded vs FDA HRT: Evidence, Safety, and Cost Comparison
Compounded vs FDA HRT differ in regulation, evidence base, dosing accuracy, and out-of-pocket cost. Here is what current guidelines from NAMS, ACOG, and the FDA say — and how telehealth menopause clinics typically prescribe.
Reviewed 5/30/2026
Estradiol Patch vs Pill: How Transdermal and Oral HRT Compare
Estradiol patch vs pill — transdermal delivery bypasses first-pass liver metabolism and carries a lower venous thromboembolism signal, while oral estradiol is cheaper and well-studied. Here is how the two compare on efficacy, safety, and cost.
Reviewed 5/30/2026
Hormonal IUD in Perimenopause: Contraception, Bleeding & HRT Use
A hormonal IUD in perimenopause does three things at once: prevents pregnancy (still possible until 12 months amenorrhea), reduces heavy bleeding by up to 90%, and provides endometrial protection if you add estrogen. Here's what the evidence shows.
Reviewed 5/30/2026
HRT After Breast Cancer: Key Considerations for Symptom Management
HRT after breast cancer raises difficult questions for survivors managing menopause symptoms. This guide reviews the current evidence base, non-hormonal alternatives, and frameworks survivors use when discussing care with oncology and menopause clinicians.
Reviewed 5/30/2026
HRT Blood Clots Risk: What the Evidence Shows About VTE and Hormone Therapy
The HRT blood clots risk varies sharply by route, formulation, age, and personal history. Transdermal estradiol shows little to no extra venous thromboembolism risk in large database studies, while oral formulations roughly double it from a low baseline.
Reviewed 5/30/2026
HRT Insurance Coverage by State: A 2026 Guide for Menopause Care
How HRT insurance coverage varies state to state in 2026 — Medicaid formularies, ACA marketplace rules, telehealth parity laws, and what's typically paid vs. cash-pay for menopause hormone therapy.
Reviewed 5/30/2026
Online HRT Prescription Process: How Virtual Menopause Care Works
A plain-English walkthrough of the online HRT prescription process: who qualifies for virtual care, what the intake asks, how clinicians screen risk, pharmacy options, and what follow-up looks like across major telehealth providers.
Reviewed 5/30/2026
Progesterone Types Compared: Micronized, Synthetic Progestins & Compounded Options
Not all progesterone is the same. Compare micronized progesterone, synthetic progestins, progestin IUDs, and compounded options on evidence, breast cancer risk, sleep effects, and how telehealth menopause clinics prescribe them.
Reviewed 5/30/2026
Telehealth Menopause by State: 2026 Coverage, Licensing & Provider Guide
A state-by-state look at telehealth menopause care in 2026 — covering provider availability, interstate licensure compacts, insurance and Medicaid telehealth parity, and how cash-pay clinics structure access.
Reviewed 5/30/2026
Hormonal Acne(16)
Adult hormonal acne: spironolactone vs combined OCPs
Two first-line options for hormonal acne in adult women. Spironolactone targets androgens; combined oral contraceptives suppress ovarian androgen production. When to pick which.
Reviewed 5/15/2026
Spironolactone for hormonal acne: dosing, monitoring, expectations
Starting at 25-50mg, titrating to 100-200mg. Effect timeline (3-6 months), potassium monitoring frequency, and managing common side effects.
Reviewed 5/15/2026
Why is my acne suddenly along my jawline?
Deep cystic lesions along jawline and chin — especially worsening premenstrual — strongly suggest hormonal driver. Testing protocols and treatment paths.
Reviewed 5/15/2026
PCOS-driven acne: combined treatment protocol
PCOS hyperandrogenism requires combined approach: spironolactone for receptor blockade, combined OCP or metformin for upstream hormonal management.
Reviewed 5/15/2026
Isotretinoin for women: pregnancy prevention and side effects
iPLEDGE requirements, dual contraception, and monthly labs make isotretinoin a significant commitment. Effects on mood, joints, and lipids that need monitoring.
Reviewed 5/15/2026
Tretinoin vs tazarotene for hormonal acne
Both topical retinoids treat hormonal acne but differ in potency, irritation profile, and pregnancy category. Selection by skin type and tolerance.
Reviewed 5/15/2026
Pregnancy-safe acne treatments when hormones spike
Most acne medications are contraindicated в pregnancy. Azelaic acid, low-dose glycolic acid, and benzoyl peroxide remain safe options для hormonally-triggered acne.
Reviewed 5/15/2026
Hormonal acne and PCOS: when adult acne is actually endocrinology
Adult-onset hormonal acne in women — particularly along the jawline — is often the first visible sign of PCOS. Topical-only treatment misses the underlying driver.
Reviewed 5/10/2026
Clomid Side Effects: Complete Guide to Risks, Frequency & Management
An evidence-based look at Clomid side effects — from common hot flashes (10-20% of users) to rare but serious risks like OHSS and visual disturbances. What the data says and when to involve a clinician.
Reviewed 5/29/2026
Hormonal Acne Treatment for Women: Evidence-Based Options in 2026
A clinician-reviewed guide to hormonal acne treatment for women — covering spironolactone, combined oral contraceptives, topical options, telehealth providers, costs, and red flags.
Reviewed 5/29/2026
Letrozole Side Effects in PCOS Fertility Treatment: A Complete Guide
Letrozole (Femara) is first-line for PCOS ovulation induction, but side effects from hot flashes to fatigue affect roughly 1 in 3 users. Here's what the trials show and how it compares to clomid.
Reviewed 5/29/2026
Metformin Side Effects in Women: A Comprehensive Guide for PCOS and Beyond
An evidence-based editorial overview of metformin side effects in women — gastrointestinal symptoms, vitamin B12 depletion, PCOS-specific considerations, and how telehealth providers approach tolerability monitoring.
Reviewed 5/29/2026
Spironolactone Side Effects in Women: A Complete Evidence-Based Guide
A detailed editorial review of spironolactone side effects in women — frequency data, dose-dependent risks, drug interactions, and what monitoring labs to discuss with a clinician.
Reviewed 5/29/2026
Menopause Dry Skin and Collagen Loss: Causes, Evidence, Options
Menopause dry skin and collagen loss accelerate sharply in the first five postmenopausal years — women lose roughly 30% of skin collagen. Here's what current evidence shows about why, and which interventions have data.
Reviewed 5/30/2026
Hair Thinning in Women: Hormonal Causes and Evidence-Based Options
A clinician-reviewed explainer on hormonal hair thinning in women — androgenetic alopecia, menopause shedding, thyroid links, PCOS, telehealth providers, costs, and red flags.
Reviewed 5/30/2026
PCOS and Perimenopause Overlap: How to Tell Symptoms Apart in 2026
A clinician-reviewed guide to PCOS perimenopause overlap — shared symptoms, what shifts after 40, lab markers that help distinguish them, and how telehealth providers approach mixed presentations.
Reviewed 5/30/2026
Weight & Metabolism(13)
Does HRT help with menopausal weight gain?
HRT does not directly cause weight loss but can shift fat distribution — reducing visceral fat. Combined with GLP-1, the effect is stronger.
Reviewed 5/15/2026
Compounded GLP-1 safety: what the FDA shortage list change means
When semaglutide left FDA shortage list in 2024, compounded versions became legally restricted. Pricing, access, and clinical implications.
Reviewed 5/15/2026
Sarcopenia: the muscle loss problem behind menopausal weight gain
Women lose 3-8% muscle per decade after 30, accelerating in menopause. Without resistance training, weight loss diets can worsen the underlying problem.
Reviewed 5/15/2026
Why do I gain weight after menopause?
Estrogen decline does shift fat distribution к visceral but does not directly cause weight gain. Sleep, NEAT, and muscle loss are bigger drivers.
Reviewed 5/15/2026
Should you start GLP-1 after menopause?
GLP-1 medications are FDA-approved without age cap but bone density loss, muscle wasting, and gallstone risk get heavier consideration in postmenopausal patients.
Reviewed 5/15/2026
How insurance covers GLP-1 for women in 2026
Coverage policies fluctuated dramatically in 2024-2025. We map current major payer rules for Wegovy, Zepbound, and PA requirements.
Reviewed 5/15/2026
Which is better для women: semaglutide or tirzepatide?
Head-to-head trial data shows tirzepatide drives ~5% greater weight loss. Both work in women but GI tolerance and dose escalation profiles differ.
Reviewed 5/15/2026
What happens when you stop taking GLP-1?
STEP-4 trial showed two-thirds of weight regained within a year of stopping semaglutide. Maintenance dosing and lifestyle integration matter more than starting dose.
Reviewed 5/15/2026
GLP-1 medications for perimenopausal weight gain
Perimenopausal weight gain has a metabolic basis that calorie restriction often can't address. GLP-1 medications target the underlying insulin resistance directly.
Reviewed 5/10/2026
GLP-1 and Menopause Weight Loss: What the Research Shows in 2026
How GLP-1 medications like semaglutide and tirzepatide perform for midlife weight gain — clinical data, side effects, drug interactions with HRT, and what to discuss with a clinician.
Reviewed 5/29/2026
Semaglutide Side Effects in Women: A Complete 2026 Guide
A clinician-reviewed look at semaglutide side effects women report most often — from nausea and constipation to menstrual shifts, hair shedding, and oral contraceptive interactions — plus what the trial data and FDA labels actually say.
Reviewed 5/29/2026
Tirzepatide Side Effects in Women: What Research Shows
Tirzepatide side effects in women span from common GI symptoms (nausea in 28-44%) to less-discussed effects on menstrual cycles, hormonal contraception, and bone health. Here's what peer-reviewed evidence shows.
Reviewed 5/29/2026
Menopause Weight Gain: Evidence-Based Management Guide for Midlife Women
Why menopause weight gain happens, what the research shows about visceral fat redistribution, and the evidence behind nutrition, strength training, HRT, and pharmacotherapy options women discuss with clinicians.
Reviewed 5/30/2026
Brain Fog & Cognition(11)
What causes brain fog in perimenopause
Fluctuating estrogen disrupts neurotransmitter activity (especially acetylcholine and serotonin). Sleep disruption and mood changes compound cognitive symptoms.
Reviewed 5/15/2026
Evidence-based cognitive strategies for brain fog
Cognitive training apps, dual-task exercise, omega-3 supplementation, and structured sleep hygiene have measurable benefit in midlife cognition studies.
Reviewed 5/15/2026
Does HRT actually help brain fog?
Observational studies suggest cognitive benefit during the "critical window" early in menopause. RCTs are mixed. We break down the data, including the WHI re-analyses.
Reviewed 5/15/2026
How can you tell brain fog от early dementia?
Both can cause word-finding issues and forgetfulness. We cover red flags that warrant neuro workup vs symptoms typical of hormonal transition.
Reviewed 5/15/2026
Can thyroid problems cause brain fog?
Subclinical hypothyroidism mimics perimenopausal brain fog. TSH alone is insufficient — full panel including free T3, free T4, and antibodies catches more cases.
Reviewed 5/15/2026
Brain fog or undiagnosed ADHD? The midlife unmasking phenomenon
Many women with previously compensated ADHD find symptoms unmasked during perimenopause as estrogen-driven dopamine support declines.
Reviewed 5/15/2026
The caffeine-brain-fog paradox: when more makes it worse
Caffeine masks early afternoon cognitive dips but worsens hot flashes and disrupts deep sleep — creating next-day brain fog. Optimal timing protocols.
Reviewed 5/15/2026
Is brain fog в perimenopause real?
Cognitive changes during the menopause transition are measurable and reversible. We cover what brain fog feels like, why it happens, and what helps.
Reviewed 5/15/2026
Brain fog in perimenopause: what's real, what's reversible
Perimenopausal brain fog is documented in fMRI and cognitive testing. It's usually reversible — but the conditions that mimic it must be ruled out.
Reviewed 5/10/2026
Hormonal Migraines in Perimenopause: Causes, Triggers, and Options
Hormonal migraines frequently intensify during perimenopause as estradiol levels swing unpredictably. Here's what current evidence shows about estrogen withdrawal, aura risk, and the options worth discussing with a clinician.
Reviewed 5/30/2026
HRT Cognitive Benefits: What the Evidence Says About Brain Fog and Dementia Risk
HRT cognitive benefits remain one of the most contested areas in menopause medicine. This evidence guide synthesizes WHIMS, KEEPS, ELITE, and 2023-2024 cohort data on perimenopausal brain fog, timing-of-initiation effects, and long-term dementia risk.
Reviewed 5/30/2026
Hot Flashes & Vasomotor(10)
Why do hot flashes happen at night?
Night sweats are hot flashes that occur during sleep — driven by hypothalamic changes from declining estrogen. Here is what helps.
Reviewed 5/15/2026
How long do hot flashes last? Real numbers from clinical research
Most women experience hot flashes for 7+ years on average — but the range is wide. We break down the timeline by age, ethnicity, and onset.
Reviewed 5/15/2026
Tracking hot flash triggers: what actually moves the needle
Caffeine, alcohol, spicy food, and stress are common triggers but vary dramatically by patient. A simple tracking framework that beats generic advice.
Reviewed 5/15/2026
What are the best non-hormonal options for hot flashes?
For women who cannot use HRT — SSRIs (paroxetine), gabapentin, oxybutynin, and the newer KNDy-targeted fezolinetant. Clinical evidence and trade-offs.
Reviewed 5/15/2026
What is fezolinetant (Veozah) and how does it work?
FDA-approved in 2023, fezolinetant blocks neurokinin-3 signaling in the hypothalamus. We cover efficacy data, side effects, cost, and prescribing patterns.
Reviewed 5/15/2026
Are estradiol patches better than oral estrogen for hot flashes?
Lower clot risk than oral estrogen, steady serum levels, and strong efficacy data make patches the recommended starting point in current Menopause Society guidelines.
Reviewed 5/15/2026
Are hot flashes and night sweats the same thing?
Both stem from hypothalamic temperature dysregulation, but night sweats disrupt sleep architecture — driving the cascade of fatigue, mood changes, and cognitive symptoms.
Reviewed 5/15/2026
How do you manage hot flashes after breast cancer?
Tamoxifen and aromatase inhibitors worsen hot flashes. Non-hormonal options including paroxetine, venlafaxine, and acupuncture have evidence in cancer survivors.
Reviewed 5/15/2026
Hot flashes: causes, mechanism, and what actually helps
Hot flashes affect 75–80% of women across the menopause transition. The mechanism is now reasonably well understood — and that understanding shapes what works.
Reviewed 5/10/2026
Hot Flashes Treatment: Evidence-Based Options for Menopause and Night Sweats
A clinician-reviewed look at hot flashes treatment — from hormone therapy and the new neurokinin-3 antagonists to lifestyle changes, telehealth access, and cost. Discuss any approach with a qualified clinician.
Reviewed 5/30/2026
Mood & Mental Health(10)
Perimenopausal anxiety: is it hormones or something else?
New-onset anxiety in midlife often signals hormonal shifts but deserves full clinical evaluation. SSRIs, HRT, and therapy each have evidence.
Reviewed 5/15/2026
How estrogen drives mood: the neurobiology explained
Estrogen modulates serotonin, dopamine, and noradrenaline synthesis and receptor sensitivity. Fluctuation — not just level — drives perimenopausal mood instability.
Reviewed 5/15/2026
PMDD worsening in perimenopause: what to do when symptoms intensify
Premenstrual dysphoric disorder often gets worse before improving in perimenopause. SSRIs, ovulation suppression, and HRT have different best-fit profiles.
Reviewed 5/15/2026
SSRI vs SNRI for menopausal mood and hot flashes
Venlafaxine and desvenlafaxine have stronger hot flash evidence; paroxetine and escitalopram win on mood-first profiles. Choosing for dual-action benefit.
Reviewed 5/15/2026
Iron deficiency and perimenopausal mood: the missing workup
Heavy perimenopausal periods drive iron loss often missed in standard labs. Low ferritin (under 50 ng/mL) correlates с fatigue, anxiety, and ADHD-like symptoms.
Reviewed 5/15/2026
Effective mood tracking during menopause transition
Daily 1-line tracking beats weekly journaling. Correlate symptoms with cycle day, sleep score, and hot flash count to surface patterns clinicians can act on.
Reviewed 5/15/2026
Is perimenopausal depression different от regular depression?
Perimenopausal depression has distinct features: tied to hormone fluctuation, often responsive to estradiol, more variable presentation. Diagnostic frameworks clinicians use.
Reviewed 5/15/2026
Mood swings vs depression in perimenopause: how to tell them apart
Perimenopausal mood changes, PMDD, and major depression overlap in symptoms but respond to different treatments. The diagnostic distinctions matter.
Reviewed 5/10/2026
Perimenopause Heart Palpitations: Causes, Patterns, and When to Seek Care
Heart palpitations during perimenopause are common but unsettling. Estrogen fluctuations, autonomic shifts, and overlapping triggers explain most episodes — here is what the research shows and how clinicians evaluate them.
Reviewed 5/30/2026
Perimenopause Mood Swings: Why They Happen and Evidence-Based Treatment Options
Perimenopause mood swings affect 40-70% of women during the menopausal transition, driven by fluctuating estradiol, sleep disruption, and prior depression history. This guide reviews evidence-based options from SSRIs and CBT to hormone therapy.
Reviewed 5/30/2026
Libido(10)
Why does libido drop в midlife?
Decreased libido in perimenopause comes from estrogen, testosterone, and vaginal tissue changes. Vaginal estrogen, off-label testosterone, and flibanserin lead the clinical toolkit.
Reviewed 5/15/2026
Vaginal estrogen: low-dose, low-systemic, high-impact
Topical estradiol creams, rings, and tablets restore vaginal tissue without significant systemic absorption. First-line for genitourinary syndrome of menopause.
Reviewed 5/15/2026
Flibanserin vs bremelanotide: comparing FDA-approved HSDD drugs
Both are FDA-approved for premenopausal HSDD but differ dramatically. Daily oral SSRI-adjacent vs on-demand injection. Side effects, efficacy, and patient fit.
Reviewed 5/15/2026
Pelvic floor dysfunction: the underdiagnosed libido issue
Pelvic floor tightness causes pain with intercourse, which extinguishes desire. Pelvic floor PT often resolves underlying physical barrier before medication.
Reviewed 5/15/2026
Libido changes after hysterectomy: ovary-sparing vs total
Removing ovaries causes immediate surgical menopause; uterus-only removal preserves natural hormone production but can still affect libido through other pathways.
Reviewed 5/15/2026
Testosterone for women: realistic side effects timeline
Acne and increased body hair are most common at higher doses. Voice changes and clitoral enlargement are rare but irreversible. Monitoring protocols.
Reviewed 5/15/2026
Can women take testosterone safely?
Despite no FDA-approved testosterone formulation for women, off-label transdermal testosterone has strong evidence for hypoactive sexual desire disorder в postmenopausal women.
Reviewed 5/15/2026
Low Libido in Perimenopause: Causes, Evidence-Based Treatment Options
Low libido in perimenopause affects up to 40% of women aged 40-55. Causes span declining estradiol, testosterone shifts, vaginal dryness (GSM), sleep disruption, and SSRIs. This guide synthesizes NAMS, ISSWSH, and ACOG evidence on treatment options.
Reviewed 5/30/2026
Testosterone for Women and Libido: What the Evidence Shows in 2026
Testosterone for women with low libido is supported by the 2019 Global Consensus Position Statement for postmenopausal HSDD. Transdermal physiologic dosing reduces sexually satisfying events versus placebo. Here's what the evidence shows and how to discuss it with a clinician.
Reviewed 5/30/2026
Vaginal Dryness Treatment Options: An Evidence Guide for Menopause
A clinician-reviewed guide to vaginal dryness treatment options during and after menopause, covering moisturizers, lubricants, hormonal therapies, DHEA, ospemifene, and what current NAMS and ACOG guidance recommends.
Reviewed 5/30/2026
Joint Pain(9)
Menopausal joint pain: estrogen's overlooked role
Joint stiffness and pain at midlife is not just aging — estrogen plays a protective role in connective tissue. HRT helps some patients; targeted exercise helps most.
Reviewed 5/15/2026
Estrogen receptors in joints: why menopause causes stiffness
ERα and ERβ receptors in cartilage, ligaments, and synovium drive joint maintenance. Estrogen withdrawal accelerates degenerative changes — measurable on MRI.
Reviewed 5/15/2026
Menopausal joint pain vs rheumatoid arthritis: differential diagnosis
Both present с morning stiffness in midlife women. Pattern of joints, lab markers (RF, CCP), and response to NSAIDs distinguish them. Don't miss treatable RA.
Reviewed 5/15/2026
Exercise protocols that help menopausal joint pain (and what makes it worse)
Low-impact high-resistance training improves joint stability and pain scores. Long-distance running and high-intensity plyometrics often worsen midlife arthralgia.
Reviewed 5/15/2026
Glucosamine and collagen supplements: separating evidence from marketing
Glucosamine has modest evidence in OA. Collagen peptides show small benefit in some trials. Neither is a substitute for resistance exercise + nutrition basics.
Reviewed 5/15/2026
Topical vs oral NSAIDs for menopausal joint pain
Topical diclofenac is now OTC and reaches therapeutic synovial levels with 90% less systemic exposure than oral NSAIDs. First-line for localized joint pain.
Reviewed 5/15/2026
Why is frozen shoulder so common в menopause?
Adhesive capsulitis disproportionately affects women 40-60 — coinciding с estrogen decline. Recent reviews suggest estrogen replacement may aid recovery.
Reviewed 5/15/2026
Estrogen Osteoporosis Prevention: Evidence, Timing, and Bone Health Options
Estrogen withdrawal at menopause triggers rapid bone loss. Here's what the evidence shows about estrogen osteoporosis prevention, the timing hypothesis, alternatives, and how to weigh options with a clinician.
Reviewed 5/30/2026
Menopause Joint Pain: Causes, Evidence, and Treatment Options
Menopause joint pain — sometimes called the menopausal arthralgia syndrome — affects roughly half of women in the transition. Here's what current evidence shows about estrogen, inflammation, and what helps.
Reviewed 5/30/2026
Sleep(8)
Best non-hormonal options for menopausal insomnia
For women who cannot or prefer not to use HRT, several non-hormonal options improve menopausal sleep — including low-dose doxepin, CBT-I, and gabapentin.
Reviewed 5/15/2026
Low-dose doxepin for menopausal insomnia: the underused option
At 3-6mg (vs 100-300mg antidepressant doses), doxepin acts as a selective H1 antagonist promoting sleep maintenance without dependency or hangover.
Reviewed 5/15/2026
CBT-I outperforms sleep medication long-term — even in menopause
Cognitive behavioral therapy for insomnia produces durable improvements unlike Z-drugs or benzodiazepines. Online programs make it accessible.
Reviewed 5/15/2026
Micronized progesterone for sleep: more than HRT
Oral progesterone converts to allopregnanolone, a GABA-A agonist with sleep-promoting effects. Bedtime dosing maximizes sleep benefit independent of menopause status.
Reviewed 5/15/2026
How does perimenopause change your sleep?
Slow-wave sleep declines, REM fragmentation increases, and arousal threshold drops. Beyond just "more night wakings" — measurable changes in PSG studies.
Reviewed 5/15/2026
Could your "menopause insomnia" actually be sleep apnea?
Estrogen protects against upper airway collapse. After menopause, sleep apnea prevalence in women catches up to men. Symptoms differ — fatigue vs snoring.
Reviewed 5/15/2026
How much melatonin should women take?
Physiologic-dose melatonin (0.1-0.5mg) outperforms pharmacologic doses for circadian timing. Higher doses cause next-day grogginess without sleep benefit.
Reviewed 5/15/2026
Perimenopause Sleep Problems: Causes, Patterns, and Evidence-Based Options
Why perimenopause sleep problems develop, how estrogen and progesterone fluctuations disrupt sleep architecture, and what evidence-based options women can discuss with a clinician.
Reviewed 5/30/2026